Related Experiment Video
Updated: Jun 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms
Takayuki Hishiki1, Yuko Shimizu, Reiri Tobita
1Research Institute, Chiba Institute of Technology, Narashino City, Chiba 275-0016, Japan. takayuki.hishiki@it-chiba.ac.jp
Insights
Apolipoprotein E (ApoE) is crucial for Hepatitis C virus (HCV) production and infectivity. ApoE facilitates infectious HCV release from cells, requiring interaction with LDL receptors and SR-BI for efficient viral spread.
Area of Science:
- Hepatology
- Virology
- Biochemistry
Background:
- Hepatitis C virus (HCV) causes chronic liver disease, cirrhosis, and cancer.
- HCV associates with lipoproteins like VLDL and LDL in blood.
- The precise role of lipoproteins in HCV production and infectivity remains unclear.
Purpose of the Study:
- To investigate the role of apolipoprotein E (ApoE) in the Hepatitis C virus (HCV) life cycle.
- To determine how ApoE influences HCV production and infectivity.
Main Methods:
- Analyzed the effect of ApoE knockdown on HCV production.
- Utilized an ApoE mutant unable to secrete into culture medium.
- Performed rescue experiments with ectopic expression of different ApoE isoforms.
- Assessed HCV infectivity in cells with varying LDLR and SR-BI expression.
Main Results:
- Knockdown of ApoE significantly reduced infectious HCV production.
- Cells with non-secretable ApoE accumulated infectious HCV intracellularly, indicating ApoE is needed for release.
- Ectopic expression of ApoE3 and ApoE4 rescued infectious HCV production, unlike ApoE2.
- HCV infectivity required both LDLR and SR-BI, which are ApoE ligands.
Conclusions:
- Apolipoprotein E (ApoE) is essential for the production and release of infectious Hepatitis C virus (HCV).
- Infectious HCV must associate with ApoE before secretion.
- HCV infectivity depends on the interaction of ApoE with host cell receptors LDLR and SR-BI.
Abstract:
Hepatitis C virus (HCV) is a causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV in circulating blood associates with lipoproteins such as very low density lipoprotein (VLDL) and low-density lipoprotein (LDL). Although these associations suggest that lipoproteins are important for HCV infectivity, the roles of lipoproteins in HCV production and infectivity are not fully understood. To clarify the roles of lipoprotein in the HCV life cycle, we analyzed the effect of apolipoprotein E (ApoE), a component of lipoprotein, on virus production and infectivity. The production of infectious HCV was significantly reduced by the knockdown of ApoE. When an ApoE mutant that fails to be secreted into the culture medium was used, the amount of infectious HCV in the culture medium was dramatically reduced; the infectious HCV accumulated inside these cells, suggesting that infectious HCV must associate with ApoE prior to virus release. We performed rescue experiments in which ApoE isoforms were ectopically expressed in cells depleted of endogenous ApoE. The ectopic expression of the ApoE2 isoform, which has low affinity for the LDL receptor (LDLR), resulted in poor recovery of infectious HCV, whereas the expression of other isoforms, ApoE3 and ApoE4, rescued the production of infectious virus, raising it to an almost normal level. Furthermore, we found that the infectivity of HCV required both the LDLR and scavenger receptor class B, member I (SR-BI), ligands for ApoE. These findings indicate that ApoE is an essential apolipoprotein for HCV infectivity.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

